Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking

Molecular and Cellular Proteomics

Volumn 13, Issue 5, 2014, Pages 1262-1272

  Gonzalez, David J ^a   Vuong, Lisa ^a   Gonzalez, Isaiah S ^a,b,c   Keller, Nadia ^a,e   McGrosso, Dominic ^a   Hwang, John H ^a   Hung, Jun ^a   Zinkernagel, Annelies ^e   Dixon, Jack E ^c,d,e   Dorrestein, Pieter C ^c,f   Nizet, Victor ^a,f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PEPTIDE; PHENOL; PHENOL SOLUBLE MODULIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; CONTROLLED STUDY; IN VITRO STUDY; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; STRESS; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE REGULATORY NETWORK; GENETIC VARIABILITY; HUMAN; IMMUNOLOGY; METABOLISM; PROCEDURES; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; CELL LINE; GENE REGULATORY NETWORKS; GENETIC VARIATION; HUMANS; MASS SPECTROMETRY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MONOCYTES; PEPTIDES; PHENOL; PROTEIN INTERACTION MAPS; PROTEOMICS; SEQUENCE HOMOLOGY, AMINO ACID; VIRULENCE FACTORS;

EID: 84899764220     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.031336     Document Type: Article

References (35)

1. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214
2. Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C., Bouffard, G. G., Blakesley, R. W., Murray, P. R., Green, E. D., Turner, M. L., and Segre, J. A. (2009) Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192
3. DeLeo, F. R., and Chambers, H. F. (2009) Reemergence of antibioticresistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119, 2464-2474
4. Datta, R., and Huang, S. S. (2008) Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin. Infect. Dis. 47, 176-181
5. Fischbach, M. A., and Walsh, C. T. (2009) Antibiotics for emerging pathogens. Science 325, 1089-1093
6. Moore, C. L., Osaki-Kiyan, P., Haque, N. Z., Perri, M. B., Donabedian, S., and Zervos, M. J. (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: A case-control study. Clin. Infect. Dis. 54, 51-58
7. Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., and Hageman, J. C. (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin. Infect. Dis. 46, 668-674
8. Sakoulas, G., and Moellering, R. C., Jr. (2008) Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis. 46 Suppl. 5, S360-S367
9. Harris, S. R., Feil, E. J., Holden, M. T., Quail, M. A., Nickerson, E. K., Chantratita, N., Gardete, S., Tavares, A., Day, N., Lindsay, J. A., Edgeworth, J. D., de Lencastre, H., Parkhill, J., Peacock, S. J., and Bentley, S. D. (2010) Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469-474
10. Traber, K. E., Lee, E., Benson, S., Corrigan, R., Cantera, M., Shopsin, B., and Novick, R. P. (2008) agr function in clinical Staphylococcus aureus isolates. Microbiology 154, 2265-2274
11. Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., and Missiakas, D. M. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23, 3393-3404
12. Dumont, A. L., Nygaard, T. K., Watkins, R. L., Smith, A., Kozhaya, L., Kreiswirth, B. N., Shopsin, B., Unutmaz, D., Voyich, J. M., and Torres, V. J. (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79, 814-825
13. Wang, R., Braughton, K. R., Kretschmer, D., Bach, T. H., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., DeLeo, F. R., and Otto, M. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13, 1510-1514
14. Periasamy, S., Joo, H. S., Duong, A. C., Bach, T. H., Tan, V. Y., Chatterjee, S. S., Cheung, G. Y., and Otto, M. (2012) How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl. Acad. Sci. U.S.A. 109, 1281-1286
15. Kretschmer, D., Nikola, N., Durr, M., Otto, M., and Peschel, A. (2012) The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2. J. Innate Immun. 4, 201-212
16. Surewaard, B. G., Nijland, R., Spaan, A. N., Kruijtzer, J. A., de Haas, C. J., and Van Strijp, J. A. (2012) Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 8, e1002606
17. Joo, H. S., Cheung, G. Y., and Otto, M. (2011) Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J. Biol. Chem. 286, 8933-8940
18. Gonzalez, D. J., Okumura, C. Y., Hollands, A., Kersten, R., Akong-Moore, K., Pence, M. A., Malone, C. L., Derieux, J., Moore, B. S., Horswill, A. R., Dixon, J. E., Dorrestein, P. C., and Nizet, V. (2012) Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J. Biol. Chem. 287, 13889-13898
19. Gonzalez, D. J., Xu, Y., Yang, Y. L., Esquenazi, E., Liu, W. T., Edlund, A., Duong, T., Du, L., Molnar, I., Gerwick, W. H., Jensen, P. R., Fischbach, M., Liaw, C. C., Straight, P., Nizet, V., and Dorrestein, P. C. (2012) Observing the invisible through imaging mass spectrometry, a window into the metabolic exchange patterns of microbes. J. Proteomics 75, 5069-5076
20. Bandeira, N., Tsur, D., Frank, A., and Pevzner, P. A. (2007) Protein identification by spectral networks analysis. Proc. Natl. Acad. Sci. U.S.A. 104, 6140-6145
21. Watrous, J., Roach, P., Alexandrov, T., Heath, B. S., Yang, J. Y., Kersten, R. D., Van Der Voort, M., Pogliano, K., Gross, H., Raaijmakers, J. M., Moore, B. S., Laskin, J., Bandeira, N., and Dorrestein, P. C. (2012) Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. U.S.A. 109, E1743-E1752
22. Guthals, A., Watrous, J. D., Dorrestein, P. C., and Bandeira, N. (2012) The spectral networks paradigm in high throughput mass spectrometry. Mol. Biosyst. 8, 2535-2544
23. Horne, K. C., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., Mayall, B. C., Johnson, P. D., and Grayson, M. L. (2009) Prospective comparison of the clinical impacts of heterogeneous vancomycinintermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob. Agents Chemother. 53, 3447-3452
24. Dhand, A., Bayer, A. S., Pogliano, J., Yang, S. J., Bolaris, M., Nizet, V., Wang, G., and Sakoulas, G. (2011) Use of antistaphylococcal betalactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: Role of enhanced daptomycin binding. Clin. Infect. Dis. 53, 158-163
25. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., and Gallo, R. L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457
26. Highlander, S. K., Hulten, K. G., Qin, X., Jiang, H., Yerrapragada, S., Mason, E. O., Jr., Shang, Y., Williams, T. M., Fortunov, R. M., Liu, Y., Igboeli, O., Petrosino, J., Tirumalai, M., Uzman, A., Fox, G. E., Cardenas, A. M., Muzny, D. M., Hemphill, L., Ding, Y., Dugan, S., Blyth, P. R., Buhay, C. J., Dinh, H. H., Hawes, A. C., Holder, M., Kovar, C. L., Lee, S. L., Liu, W., Nazareth, L. V., Wang, Q., Zhou, J., Kaplan, S. L., and Weinstock, G. M. (2007) Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 7, 99
27. Yamaki, J., Synold, T., and Wong-Beringer, A. (2011) Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins. Antimicrob. Agents Chemother. 55, 4432-4435
28. Forsman, H., Christenson, K., Bylund, J., and Dahlgren, C. (2012) Receptordependent and-independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect. Immun. 80, 1987-1995
29. Joo, H. S., Chan, J. L., Cheung, G. Y., and Otto, M. (2010) Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillinresistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 4942-4944
30. Cheung, G. Y., Duong, A. C., and Otto, M. (2012) Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: Implications for diagnosis and pathogenesis. Microbes Infect. 14, 380-386
31. Kerr, I. D., Doak, D. G., Sankararamakrishnan, R., Breed, J., and Sansom, M. S. (1996) Molecular modelling of Staphylococcal delta-toxin ion channels by restrained molecular dynamics. Protein Eng. 9, 161-171
32. Montgomery, C. P., Boyle-Vavra, S., and Daum, R. S. (2010) Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5, e15177
33. Bahcall, O. G. (2013) MRSA evolution and spread. Nat. Genet. 45, 123
34. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L. H., Lynfield, R., Dumyati, G., Townes, J. M., Craig, A. S., Zell, E. R., Fosheim, G. E., McDougal, L. K., Carey, R. B., and Fridkin, S. K. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763-1771
35. Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., Sensabaugh, G. F., and Perdreau-Remington, F. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367, 731-739